InvestorsHub Logo
Followers 0
Posts 3
Boards Moderated 0
Alias Born 04/26/2016

Re: ahab333 post# 35305

Thursday, 05/19/2016 5:05:57 PM

Thursday, May 19, 2016 5:05:57 PM

Post# of 48316
Some random thoughts on my first post here... Part of this decline today might be that the final announcement of ASCO abstracts or presentations was yesterday, and Oncosec is not in it. Some might have been expecting it and sold today. Bio indexes are down too. There could still be an ASCO effect for Oncosec. In February ASCO called immunotherapy the cancer treatment of the year. There will be some announcements from ASCO that could lift all boats including Oncosec. Look at what ADSX announcement did two months ago....

The retail float is only about 11 million shares. The Apr 20 surge was nearly 8 million trades. There had to be some serious shorting, including naked as suggested by others here. Have they all covered yet? Probably not. As others have said this is a trading stock. My hope is its being driven down to low entry points and we will begin a cycle of uptrend, or maybe anticipation of ASCO effect. The PPS is painful, doesn't reflect the potential of the science. Keep in mind several companies have PD-1 therapies, and may want to get a competitive advantage by partnering with ONCS to reach non-responders. GLTA